OR WAIT null SECS
April 14, 2026
Video
Blood discusses his recent study of the RECTIFIER AI model, highlighting its superior sensitivity and accuracy compared to physicians.
April 09, 2026
Article
Catch up on major trial results, groundbreaking guideline updates, and more.
April 06, 2026
Catch up on data from some of the most impactful trials presented at the American College of Cardiology 2026.
April 03, 2026
Catch up on the most impactful trial readouts to come out of ACC 2026.
April 01, 2026
Martinez discusses the bigger picture of mavacamten, highlighting its safety and efficacy as well as recent real-world trial data in patients with HCM.
Rossano discusses the results of the phase 3 SCOUT-HCM trial, highlighting mavacamten’s comparative superiority in reducing left ventricular outflow.
March 30, 2026
New information from the phase 3 SCOUT-HCM trial indicate the benefits of mavacamten may extend to adolescents as well as adults.
February 02, 2026
Catch up with major FDA decisions, key guidelines updates, and more.
January 12, 2026
Bristol Myers Squibb has reported positive results from the ongoing SCOUT-HCM trial, demonstrating mavacamten’s efficacy in reducing Valsalva LVOT.
January 09, 2026
The Q4 recap for cardiology spotlights major FDA decisions, key clinical trial updates, and more.
